Calico is the new Google-ism for a new and apparently separate company which will focus on health and wellbeing, concentrating on aging and associated diseases. Announced yesterday, it will be headed by Arthur D. Levinson, Chairman of both Genentech and Apple, who plans to remain in both day jobs. It’s way outside of Google’s main business model, but in sync with the (failed) Google Health PHR, the potential of Glass in medicine and their relationship with Cornell NYC Tech, which until 2017 is in substantial space in Google’s sprawling downtown Manhattan building; one of the latter’s tech entrepreneurship hubs is ‘healthier life’. Google is also willing to spend floods of money on this without any ROI in the foreseeable future–even the driverless car has a far closer horizon to reality. Other than the release, pretty much copied on Gizmag, Google is Mum. TIME’s cover story next week is only partly available without subscription but the cover (left above) is priceless. Along with it is an interesting bit of speculation on Mr. Levinson’s potential conflicts of interests in this third for him venture which are of perennial interest to the Federal Trade Commission (FTC).